Differential microRNA expression in the peripheral blood from human patients with COVID‐19
Introduction The coronavirus disease (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which play important roles in regulating gene expression and are also considered as essential modulators during viral infection. The aim of this study was to elucidate the diffe...
Saved in:
| Published in | Journal of clinical laboratory analysis Vol. 34; no. 10; pp. e23590 - n/a |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
John Wiley & Sons, Inc
01.10.2020
John Wiley and Sons Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0887-8013 1098-2825 1098-2825 |
| DOI | 10.1002/jcla.23590 |
Cover
Loading…
| Abstract | Introduction
The coronavirus disease (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which play important roles in regulating gene expression and are also considered as essential modulators during viral infection. The aim of this study was to elucidate the differential expression of miRNAs in COVID‐19.
Methods
The total RNA was extracted and purified from the peripheral blood of ten patients with COVID‐19 and four healthy donors. The expression levels of various miRNAs were detected by high‐throughput sequencing, and correlation analysis was performed on the target genes that are primed by miRNAs.
Key findings
Compared with the healthy controls, 35 miRNAs were upregulated and 38 miRNAs were downregulated in the human patients with COVID‐19. The top 10 genes were listed below: hsa‐miR‐16‐2‐3P,hsa‐miR‐5695,hsa‐miR‐10399‐3P,hsa‐miR‐6501‐5P,hsa‐miR‐361‐3P,hsa‐miR‐361‐3p, hsa‐miR‐4659a‐3p, hsa‐miR‐142‐5p, hsa‐miR‐4685‐3p, hsa‐miR‐454‐5p, and hsa‐miR‐30c‐5p. The 10 genes with the greatest reduction were listed below: hsa‐miR‐183‐5p, hsa‐miR‐627‐5p, hsa‐miR‐941, hsa‐miR‐21‐5p, hsa‐miR‐20a‐5p, hsa‐miR‐146b‐5p, hsa‐miR‐454‐3p, hsa‐miR‐18a‐5p, hsa‐miR‐340‐5p, and hsa‐miR‐17‐5p. Remarkably, miR‐16‐2‐3p was the most upregulated miRNA, with a 1.6‐fold change compared to that of the controls. Moreover, the expression of miR‐6501‐5p and miR‐618 was 1.5‐fold higher in the COVID‐19 patients than in the healthy donors. Meanwhile, miR‐627‐5p was the most downregulated miRNA, with a 2.3‐fold change compared to that of the controls. The expression of other miRNAs (miR‐183‐5p, miR‐627‐5p, and miR‐144‐3p) was reduced by more than 1.3‐fold compared to that of the healthy donors. Cluster analysis revealed that all of the differentially expressed miRNA target genes were clustered by their regulation of cellular components, molecular functions, and biological processes. Importantly, peptidases, protein kinases, and the ubiquitin system were shown to be the highest enrichment categories by enrichment analysis.
Conclusions
The differential miRNA expression found in COVID‐19 patients may regulate the immune responses and viral replication during viral infection.
Extract periperal blood cells from COVID‐19 patients, and micRNAs were detected by high‐throughput sequencing using illumina HiseqX Ten machine to fint the differential expression of miRNAs in COVID‐19. |
|---|---|
| AbstractList | IntroductionThe coronavirus disease (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which play important roles in regulating gene expression and are also considered as essential modulators during viral infection. The aim of this study was to elucidate the differential expression of miRNAs in COVID‐19.MethodsThe total RNA was extracted and purified from the peripheral blood of ten patients with COVID‐19 and four healthy donors. The expression levels of various miRNAs were detected by high‐throughput sequencing, and correlation analysis was performed on the target genes that are primed by miRNAs.Key findingsCompared with the healthy controls, 35 miRNAs were upregulated and 38 miRNAs were downregulated in the human patients with COVID‐19. The top 10 genes were listed below: hsa‐miR‐16‐2‐3P,hsa‐miR‐5695,hsa‐miR‐10399‐3P,hsa‐miR‐6501‐5P,hsa‐miR‐361‐3P,hsa‐miR‐361‐3p, hsa‐miR‐4659a‐3p, hsa‐miR‐142‐5p, hsa‐miR‐4685‐3p, hsa‐miR‐454‐5p, and hsa‐miR‐30c‐5p. The 10 genes with the greatest reduction were listed below: hsa‐miR‐183‐5p, hsa‐miR‐627‐5p, hsa‐miR‐941, hsa‐miR‐21‐5p, hsa‐miR‐20a‐5p, hsa‐miR‐146b‐5p, hsa‐miR‐454‐3p, hsa‐miR‐18a‐5p, hsa‐miR‐340‐5p, and hsa‐miR‐17‐5p. Remarkably, miR‐16‐2‐3p was the most upregulated miRNA, with a 1.6‐fold change compared to that of the controls. Moreover, the expression of miR‐6501‐5p and miR‐618 was 1.5‐fold higher in the COVID‐19 patients than in the healthy donors. Meanwhile, miR‐627‐5p was the most downregulated miRNA, with a 2.3‐fold change compared to that of the controls. The expression of other miRNAs (miR‐183‐5p, miR‐627‐5p, and miR‐144‐3p) was reduced by more than 1.3‐fold compared to that of the healthy donors. Cluster analysis revealed that all of the differentially expressed miRNA target genes were clustered by their regulation of cellular components, molecular functions, and biological processes. Importantly, peptidases, protein kinases, and the ubiquitin system were shown to be the highest enrichment categories by enrichment analysis.ConclusionsThe differential miRNA expression found in COVID‐19 patients may regulate the immune responses and viral replication during viral infection. Introduction The coronavirus disease (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which play important roles in regulating gene expression and are also considered as essential modulators during viral infection. The aim of this study was to elucidate the differential expression of miRNAs in COVID‐19. Methods The total RNA was extracted and purified from the peripheral blood of ten patients with COVID‐19 and four healthy donors. The expression levels of various miRNAs were detected by high‐throughput sequencing, and correlation analysis was performed on the target genes that are primed by miRNAs. Key findings Compared with the healthy controls, 35 miRNAs were upregulated and 38 miRNAs were downregulated in the human patients with COVID‐19. The top 10 genes were listed below: hsa‐miR‐16‐2‐3P,hsa‐miR‐5695,hsa‐miR‐10399‐3P,hsa‐miR‐6501‐5P,hsa‐miR‐361‐3P,hsa‐miR‐361‐3p, hsa‐miR‐4659a‐3p, hsa‐miR‐142‐5p, hsa‐miR‐4685‐3p, hsa‐miR‐454‐5p, and hsa‐miR‐30c‐5p. The 10 genes with the greatest reduction were listed below: hsa‐miR‐183‐5p, hsa‐miR‐627‐5p, hsa‐miR‐941, hsa‐miR‐21‐5p, hsa‐miR‐20a‐5p, hsa‐miR‐146b‐5p, hsa‐miR‐454‐3p, hsa‐miR‐18a‐5p, hsa‐miR‐340‐5p, and hsa‐miR‐17‐5p. Remarkably, miR‐16‐2‐3p was the most upregulated miRNA, with a 1.6‐fold change compared to that of the controls. Moreover, the expression of miR‐6501‐5p and miR‐618 was 1.5‐fold higher in the COVID‐19 patients than in the healthy donors. Meanwhile, miR‐627‐5p was the most downregulated miRNA, with a 2.3‐fold change compared to that of the controls. The expression of other miRNAs (miR‐183‐5p, miR‐627‐5p, and miR‐144‐3p) was reduced by more than 1.3‐fold compared to that of the healthy donors. Cluster analysis revealed that all of the differentially expressed miRNA target genes were clustered by their regulation of cellular components, molecular functions, and biological processes. Importantly, peptidases, protein kinases, and the ubiquitin system were shown to be the highest enrichment categories by enrichment analysis. Conclusions The differential miRNA expression found in COVID‐19 patients may regulate the immune responses and viral replication during viral infection. Extract periperal blood cells from COVID‐19 patients, and micRNAs were detected by high‐throughput sequencing using illumina HiseqX Ten machine to fint the differential expression of miRNAs in COVID‐19. The coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which play important roles in regulating gene expression and are also considered as essential modulators during viral infection. The aim of this study was to elucidate the differential expression of miRNAs in COVID-19.INTRODUCTIONThe coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which play important roles in regulating gene expression and are also considered as essential modulators during viral infection. The aim of this study was to elucidate the differential expression of miRNAs in COVID-19.The total RNA was extracted and purified from the peripheral blood of ten patients with COVID-19 and four healthy donors. The expression levels of various miRNAs were detected by high-throughput sequencing, and correlation analysis was performed on the target genes that are primed by miRNAs.METHODSThe total RNA was extracted and purified from the peripheral blood of ten patients with COVID-19 and four healthy donors. The expression levels of various miRNAs were detected by high-throughput sequencing, and correlation analysis was performed on the target genes that are primed by miRNAs.Compared with the healthy controls, 35 miRNAs were upregulated and 38 miRNAs were downregulated in the human patients with COVID-19. The top 10 genes were listed below: hsa-miR-16-2-3P,hsa-miR-5695,hsa-miR-10399-3P,hsa-miR-6501-5P,hsa-miR-361-3P,hsa-miR-361-3p, hsa-miR-4659a-3p, hsa-miR-142-5p, hsa-miR-4685-3p, hsa-miR-454-5p, and hsa-miR-30c-5p. The 10 genes with the greatest reduction were listed below: hsa-miR-183-5p, hsa-miR-627-5p, hsa-miR-941, hsa-miR-21-5p, hsa-miR-20a-5p, hsa-miR-146b-5p, hsa-miR-454-3p, hsa-miR-18a-5p, hsa-miR-340-5p, and hsa-miR-17-5p. Remarkably, miR-16-2-3p was the most upregulated miRNA, with a 1.6-fold change compared to that of the controls. Moreover, the expression of miR-6501-5p and miR-618 was 1.5-fold higher in the COVID-19 patients than in the healthy donors. Meanwhile, miR-627-5p was the most downregulated miRNA, with a 2.3-fold change compared to that of the controls. The expression of other miRNAs (miR-183-5p, miR-627-5p, and miR-144-3p) was reduced by more than 1.3-fold compared to that of the healthy donors. Cluster analysis revealed that all of the differentially expressed miRNA target genes were clustered by their regulation of cellular components, molecular functions, and biological processes. Importantly, peptidases, protein kinases, and the ubiquitin system were shown to be the highest enrichment categories by enrichment analysis.KEY FINDINGSCompared with the healthy controls, 35 miRNAs were upregulated and 38 miRNAs were downregulated in the human patients with COVID-19. The top 10 genes were listed below: hsa-miR-16-2-3P,hsa-miR-5695,hsa-miR-10399-3P,hsa-miR-6501-5P,hsa-miR-361-3P,hsa-miR-361-3p, hsa-miR-4659a-3p, hsa-miR-142-5p, hsa-miR-4685-3p, hsa-miR-454-5p, and hsa-miR-30c-5p. The 10 genes with the greatest reduction were listed below: hsa-miR-183-5p, hsa-miR-627-5p, hsa-miR-941, hsa-miR-21-5p, hsa-miR-20a-5p, hsa-miR-146b-5p, hsa-miR-454-3p, hsa-miR-18a-5p, hsa-miR-340-5p, and hsa-miR-17-5p. Remarkably, miR-16-2-3p was the most upregulated miRNA, with a 1.6-fold change compared to that of the controls. Moreover, the expression of miR-6501-5p and miR-618 was 1.5-fold higher in the COVID-19 patients than in the healthy donors. Meanwhile, miR-627-5p was the most downregulated miRNA, with a 2.3-fold change compared to that of the controls. The expression of other miRNAs (miR-183-5p, miR-627-5p, and miR-144-3p) was reduced by more than 1.3-fold compared to that of the healthy donors. Cluster analysis revealed that all of the differentially expressed miRNA target genes were clustered by their regulation of cellular components, molecular functions, and biological processes. Importantly, peptidases, protein kinases, and the ubiquitin system were shown to be the highest enrichment categories by enrichment analysis.The differential miRNA expression found in COVID-19 patients may regulate the immune responses and viral replication during viral infection.CONCLUSIONSThe differential miRNA expression found in COVID-19 patients may regulate the immune responses and viral replication during viral infection. Extract periperal blood cells from COVID‐19 patients, and micRNAs were detected by high‐throughput sequencing using illumina HiseqX Ten machine to fint the differential expression of miRNAs in COVID‐19. The coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which play important roles in regulating gene expression and are also considered as essential modulators during viral infection. The aim of this study was to elucidate the differential expression of miRNAs in COVID-19. The total RNA was extracted and purified from the peripheral blood of ten patients with COVID-19 and four healthy donors. The expression levels of various miRNAs were detected by high-throughput sequencing, and correlation analysis was performed on the target genes that are primed by miRNAs. Compared with the healthy controls, 35 miRNAs were upregulated and 38 miRNAs were downregulated in the human patients with COVID-19. The top 10 genes were listed below: hsa-miR-16-2-3P,hsa-miR-5695,hsa-miR-10399-3P,hsa-miR-6501-5P,hsa-miR-361-3P,hsa-miR-361-3p, hsa-miR-4659a-3p, hsa-miR-142-5p, hsa-miR-4685-3p, hsa-miR-454-5p, and hsa-miR-30c-5p. The 10 genes with the greatest reduction were listed below: hsa-miR-183-5p, hsa-miR-627-5p, hsa-miR-941, hsa-miR-21-5p, hsa-miR-20a-5p, hsa-miR-146b-5p, hsa-miR-454-3p, hsa-miR-18a-5p, hsa-miR-340-5p, and hsa-miR-17-5p. Remarkably, miR-16-2-3p was the most upregulated miRNA, with a 1.6-fold change compared to that of the controls. Moreover, the expression of miR-6501-5p and miR-618 was 1.5-fold higher in the COVID-19 patients than in the healthy donors. Meanwhile, miR-627-5p was the most downregulated miRNA, with a 2.3-fold change compared to that of the controls. The expression of other miRNAs (miR-183-5p, miR-627-5p, and miR-144-3p) was reduced by more than 1.3-fold compared to that of the healthy donors. Cluster analysis revealed that all of the differentially expressed miRNA target genes were clustered by their regulation of cellular components, molecular functions, and biological processes. Importantly, peptidases, protein kinases, and the ubiquitin system were shown to be the highest enrichment categories by enrichment analysis. The differential miRNA expression found in COVID-19 patients may regulate the immune responses and viral replication during viral infection. |
| Author | Li, Caixia Li, Leilei Li, Jin‐hui Hu, Xiao |
| AuthorAffiliation | 1 Department of General practice School of Medicine The Fourth Affiliated Hospital Zhejiang University Yiwu China 6 Department of Rehabilitation and Traditional Chinese Medicine The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou China 4 Department of Operating Room School of Medicine The Fourth Affiliated Hospital Zhejiang University Yiwu China 2 Department of Anesthesiology The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou China 3 Department of Laboratory Medicine School of Medicine The Fourth Affiliated Hospital Zhejiang University Yiwu China 5 Department of Rehabilitation Medicine School of Medicine The Fourth Affiliated Hospital Zhejiang University Yiwu China |
| AuthorAffiliation_xml | – name: 1 Department of General practice School of Medicine The Fourth Affiliated Hospital Zhejiang University Yiwu China – name: 2 Department of Anesthesiology The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou China – name: 6 Department of Rehabilitation and Traditional Chinese Medicine The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou China – name: 4 Department of Operating Room School of Medicine The Fourth Affiliated Hospital Zhejiang University Yiwu China – name: 3 Department of Laboratory Medicine School of Medicine The Fourth Affiliated Hospital Zhejiang University Yiwu China – name: 5 Department of Rehabilitation Medicine School of Medicine The Fourth Affiliated Hospital Zhejiang University Yiwu China |
| Author_xml | – sequence: 1 givenname: Caixia orcidid: 0000-0002-2128-8862 surname: Li fullname: Li, Caixia organization: Zhejiang University – sequence: 2 givenname: Xiao surname: Hu fullname: Hu, Xiao organization: Zhejiang University – sequence: 3 givenname: Leilei surname: Li fullname: Li, Leilei organization: Zhejiang University – sequence: 4 givenname: Jin‐hui surname: Li fullname: Li, Jin‐hui email: 2311045@zju.edu.cn organization: The Second Affiliated Hospital of Zhejiang University School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32960473$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc9u1DAYxC1URLctFx4AWeKCkFI-24n_XJBWW6BFKyoh4IRkOYlDvEri1E4ovfEIPCNPUi9bKlohTj74N6P5Zg7Q3uAHi9ATAscEgL7cVJ05pqxQ8AAtCCiZUUmLPbQAKUUmgbB9dBDjBgCkIvwR2mdUccgFW6AvJ65pbLDD5EyHe1cF_-H9EtvvY7AxOj9gN-CptXi0wY2tDYkqO-9r3ATf43buzYBHM7nkEPGlm1q8Ov98dvLrx0-ijtDDxnTRPr55D9GnN68_rk6z9fnbs9VynVW54JDxppS5gAbKgrMKJKecCioYYaWkTCkJVnJrjCxzZqu6kYbVIGrRMMNUUZfsEL3a-Y5z2du6SllSTj0G15twpb1x-u7P4Fr91X_TomBcCZoMnt8YBH8x2zjp3sXKdp0ZrJ-jpnmeS8FzxhL67B668XMY0nmJKgqec1Bbw6d_J7qN8qf4BLzYAanwGINtbhECeruq3q6qf6-aYLgHV25KnfvtNa77t4TsJJeus1f_MdfvVuvlTnMN2xS0zw |
| CitedBy_id | crossref_primary_10_3389_fphar_2022_857730 crossref_primary_10_1155_2022_1645366 crossref_primary_10_1007_s11033_021_06378_x crossref_primary_10_3390_pathogens13100854 crossref_primary_10_20463_pan_2021_0008 crossref_primary_10_1111_jcmm_17492 crossref_primary_10_1002_jmv_27093 crossref_primary_10_3390_ijms23169239 crossref_primary_10_1038_s41598_021_86134_0 crossref_primary_10_3390_ijms242015471 crossref_primary_10_3390_ncrna10050048 crossref_primary_10_1038_s41467_024_47463_6 crossref_primary_10_3390_jpm12020324 crossref_primary_10_1007_s11033_022_07338_9 crossref_primary_10_1080_15476286_2021_2010959 crossref_primary_10_1371_journal_pone_0286871 crossref_primary_10_3390_ncrna8030029 crossref_primary_10_1093_bfgp_elad010 crossref_primary_10_1016_j_meegid_2021_105020 crossref_primary_10_1186_s40001_021_00544_4 crossref_primary_10_1016_j_virusres_2022_198853 crossref_primary_10_1080_22221751_2022_2038021 crossref_primary_10_1002_jcla_24666 crossref_primary_10_1111_odi_14351 crossref_primary_10_3390_v15051177 crossref_primary_10_1016_j_arcmed_2024_103114 crossref_primary_10_3389_fmed_2021_756517 crossref_primary_10_1016_j_genrep_2022_101641 crossref_primary_10_3390_ijms231911058 crossref_primary_10_1093_bib_bbab397 crossref_primary_10_3390_cells10123504 crossref_primary_10_3390_v14010041 crossref_primary_10_1038_s41598_024_64775_1 crossref_primary_10_1073_pnas_2116668118 crossref_primary_10_1002_rmv_2449 crossref_primary_10_1007_s13258_021_01119_7 crossref_primary_10_1016_j_vetmic_2022_109595 crossref_primary_10_3389_fimmu_2023_1098688 crossref_primary_10_1016_j_omtn_2022_07_005 crossref_primary_10_3390_sym13071307 crossref_primary_10_1002_jmv_26909 crossref_primary_10_1038_s41598_023_40754_w crossref_primary_10_1186_s43141_023_00565_y crossref_primary_10_3389_fimmu_2022_975848 crossref_primary_10_1016_j_pathol_2021_09_006 crossref_primary_10_3390_life12121964 crossref_primary_10_1093_bib_bbad203 crossref_primary_10_2217_fvl_2020_0389 crossref_primary_10_1093_cvr_cvab094 crossref_primary_10_1096_fj_202001952R crossref_primary_10_3389_fnagi_2022_1020092 crossref_primary_10_1016_j_jmccpl_2022_100013 crossref_primary_10_15275_rusomj_2022_0313 crossref_primary_10_3390_cells10071762 crossref_primary_10_1016_j_ncrna_2024_08_007 crossref_primary_10_1038_s41598_024_64325_9 crossref_primary_10_1016_j_ibneur_2022_10_005 crossref_primary_10_1159_000533606 crossref_primary_10_1016_j_jiph_2022_06_012 crossref_primary_10_3390_ijms24021611 crossref_primary_10_1016_j_gene_2023_147232 crossref_primary_10_1016_j_gene_2021_146069 crossref_primary_10_1016_j_prmcm_2022_100049 crossref_primary_10_1080_15476286_2022_2100629 crossref_primary_10_1109_TCBB_2024_3351752 crossref_primary_10_1002_cbin_11653 crossref_primary_10_3390_ijms22073792 crossref_primary_10_3389_fcell_2023_1229393 crossref_primary_10_1016_j_prp_2024_155155 crossref_primary_10_1038_s41392_023_01669_0 crossref_primary_10_3390_biom11060844 crossref_primary_10_3389_fmed_2024_1430974 crossref_primary_10_1016_j_meegid_2021_105195 crossref_primary_10_1093_cvr_cvab201 crossref_primary_10_1080_15384101_2020_1867792 crossref_primary_10_1159_000529985 crossref_primary_10_1124_jpet_122_001210 crossref_primary_10_2174_26669587_v2_e221026_2022_23 crossref_primary_10_1016_j_heliyon_2023_e13388 crossref_primary_10_1186_s13148_023_01515_8 crossref_primary_10_1038_s41569_021_00665_7 crossref_primary_10_3389_fimmu_2022_918692 crossref_primary_10_3390_v15020496 crossref_primary_10_7759_cureus_23636 crossref_primary_10_1016_j_semcdb_2023_02_006 crossref_primary_10_3390_ijms23073649 crossref_primary_10_3390_ijms232012292 crossref_primary_10_3390_microbiolres13040056 crossref_primary_10_3389_fmicb_2022_1089729 crossref_primary_10_3390_genes13071146 crossref_primary_10_53730_ijhs_v6nS2_6277 crossref_primary_10_1038_s41598_022_23533_x crossref_primary_10_2217_bmm_2021_0348 crossref_primary_10_3389_fnmol_2023_1123955 crossref_primary_10_3390_diagnostics13010133 crossref_primary_10_1007_s00705_024_06184_3 crossref_primary_10_3390_ijms22168663 crossref_primary_10_1039_D2SD00140C crossref_primary_10_1186_s40246_023_00494_4 crossref_primary_10_1007_s00251_023_01308_6 crossref_primary_10_1007_s00705_023_05825_3 crossref_primary_10_1111_liv_16079 crossref_primary_10_1016_j_omtn_2022_06_006 crossref_primary_10_1371_journal_pone_0283589 crossref_primary_10_3390_cells12192421 crossref_primary_10_1038_s41598_022_23922_2 crossref_primary_10_3390_biomedicines9121823 crossref_primary_10_1038_s41598_023_30474_6 crossref_primary_10_2147_IJGM_S354885 crossref_primary_10_1186_s43042_023_00451_9 crossref_primary_10_3390_diagnostics13061091 crossref_primary_10_3390_genes13020348 crossref_primary_10_1007_s11239_021_02468_6 crossref_primary_10_1016_j_intimp_2022_109040 crossref_primary_10_1093_bib_bbab062 crossref_primary_10_1016_j_humgen_2023_201172 crossref_primary_10_1016_j_meegid_2021_104832 crossref_primary_10_17826_cumj_1415977 crossref_primary_10_3389_frma_2021_683212 crossref_primary_10_1007_s11906_021_01138_5 crossref_primary_10_2174_1389200223666220321102824 crossref_primary_10_1016_j_trsl_2021_05_004 crossref_primary_10_1038_s41540_024_00367_z crossref_primary_10_1186_s12967_020_02582_8 crossref_primary_10_1038_s41420_022_01005_5 crossref_primary_10_3390_ijms24032380 |
| Cites_doi | 10.2147/OTT.S219440 10.1186/s13099-020-00353-w 10.1016/S0140-6736(20)30186-0 10.1371/journal.pgen.1008765 10.1016/S0140-6736(20)30317-2 10.1002/art.40163 10.7150/jca.42498 10.3389/fendo.2019.00385 10.1056/NEJMe2001329 10.1126/science.abb8925 10.1038/s41591-020-0771-1 10.1016/j.thromres.2019.03.005 10.3389/fcimb.2018.00278 10.1080/22221751.2020.1719902 10.1016/j.ygeno.2020.04.016 10.1056/NEJMc2001468 10.1056/NEJMoa2001191 10.1056/NEJMc2001272 |
| ContentType | Journal Article |
| Copyright | 2020 The Authors. Published by Wiley Periodicals LLC 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals LLC. 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2020 The Authors. Published by Wiley Periodicals LLC – notice: 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals LLC. – notice: 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7T5 7U9 7X7 7XB 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1002/jcla.23590 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Coronavirus Research Database ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | LI et al |
| EISSN | 1098-2825 |
| EndPage | n/a |
| ExternalDocumentID | PMC7536972 32960473 10_1002_jcla_23590 JCLA23590 |
| Genre | article Journal Article |
| GrantInformation_xml | – fundername: Jinhua Science and Technology Bureau new Crown research key project in Zhejiang Province funderid: 2020XG‐30 – fundername: Jinhua Science and Technology Bureau funderid: 2020XG‐30 – fundername: Jinhua Science and Technology Bureau grantid: 2020XG-30 – fundername: Jinhua Science and Technology Bureau new Crown research key project in Zhejiang Province grantid: 2020XG-30 – fundername: Jinhua Science and Technology Bureau new Crown research key project in Zhejiang Province grantid: 2020XG‐30 – fundername: ; grantid: 2020XG‐30 |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 6PF 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8C1 8FI 8FJ 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AANHP AAONW AAWTL AAZKR ABCQN ABEML ABIJN ABPVW ABUWG ACBWZ ACCFJ ACCMX ACGFS ACMXC ACPRK ACRPL ACSCC ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADNMO ADPDF ADZMN AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFKRA AFPWT AFZJQ AHMBA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ASPBG ATUGU AVUZU AVWKF AZBYB AZFZN AZVAB BAFTC BBNVY BCNDV BDRZF BENPR BFHJK BHBCM BHPHI BMXJE BROTX BRXPI BY8 CCPQU CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DU5 DUUFO EBD EBS EJD EMOBN F00 F01 F04 F1Z F5P FEDTE FUBAC FYUFA G-S G.N GNP GODZA GROUPED_DOAJ H.X HBH HCIFZ HF~ HHY HMCUK HVGLF HYE HZ~ IAO IHR ITC IX1 J0M JPC KQQ LAW LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 M65 M7P MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD OVEED P2P P2W P2X P2Z P4B P4D PALCI PIMPY PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RPM RWI RX1 SAMSI SUPJJ SV3 TEORI TWZ UB1 UKHRP V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XPP XV2 ~IA ~WT AAYXX AGQPQ CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7QP 7T5 7U9 7XB 8FE 8FH 8FK AAMMB AEFGJ AGXDD AIDQK AIDYY AZQEC COVID DWQXO GNUQQ H94 K9. LK8 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c4760-6fb8470f0b563c086262727313b8239980e86eaa8b43ecdf8a3d07d7f3a395db3 |
| IEDL.DBID | 24P |
| ISSN | 0887-8013 1098-2825 |
| IngestDate | Thu Aug 21 18:18:44 EDT 2025 Fri Jul 11 07:51:27 EDT 2025 Wed Aug 13 08:20:00 EDT 2025 Thu Apr 03 07:08:32 EDT 2025 Tue Jul 01 02:27:44 EDT 2025 Thu Apr 24 22:58:37 EDT 2025 Wed Jan 22 16:59:46 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | Bioinformatics analysis COVID-19 microRNA high-throughput sequencing |
| Language | English |
| License | Attribution 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4760-6fb8470f0b563c086262727313b8239980e86eaa8b43ecdf8a3d07d7f3a395db3 |
| Notes | Funding information Caixia Li and Xiao Hu contributed to this work equally. This study was supported by the Jinhua Science and Technology Bureau new Crown research key project in Zhejiang Province, China (2020XG‐30). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-2128-8862 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcla.23590 |
| PMID | 32960473 |
| PQID | 2455646092 |
| PQPubID | 105667 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7536972 proquest_miscellaneous_2444876433 proquest_journals_2455646092 pubmed_primary_32960473 crossref_primary_10_1002_jcla_23590 crossref_citationtrail_10_1002_jcla_23590 wiley_primary_10_1002_jcla_23590_JCLA23590 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | October 2020 |
| PublicationDateYYYYMMDD | 2020-10-01 |
| PublicationDate_xml | – month: 10 year: 2020 text: October 2020 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: New York – name: Hoboken |
| PublicationTitle | Journal of clinical laboratory analysis |
| PublicationTitleAlternate | J Clin Lab Anal |
| PublicationYear | 2020 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
| References | 2018; 8 2020; 382 2017; 69 2020; 395 2019; 10 2017; 21 2019; 12 2020; 91 2020; 9 2020; 368 2020; 16 2020; 26 2020; 112 2020; 12 2020; 11 2019; 177 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_3_1 Li W (e_1_2_7_14_1) 2020; 11 e_1_2_7_9_1 Wang WW (e_1_2_7_19_1) 2017; 21 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 Santos‐Bezerra Daniele P (e_1_2_7_20_1) 2019; 10 Li B (e_1_2_7_21_1) 2019; 12 Canatan D (e_1_2_7_17_1) 2020; 91 Nkengasong J (e_1_2_7_4_1) 2020; 26 |
| References_xml | – volume: 16 year: 2020 article-title: Dynamic miRNA‐mRNA interactions coordinate gene expression in adult Anopheles gambiae publication-title: PLoS Genet – volume: 368 start-page: 473 year: 2020 end-page: 474 article-title: Cytokine release syndrome in severe COVID‐19 publication-title: Science – volume: 12 start-page: 9795 year: 2019 end-page: 9807 article-title: MicroRNA‐618 Directly Targets Metadherin mRNA To Suppress The Malignant Phenotype Of Osteosarcoma Cells By Reducing PTEN‐AKT Pathway Output publication-title: Onco Targets Ther – volume: 91 start-page: 195 year: 2020 end-page: 198 article-title: The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses publication-title: Acta Biomed – volume: 395 start-page: 311 year: 2020 article-title: Emerging understandings of 2019‐nCoV publication-title: Lancet – volume: 8 start-page: 278 year: 2018 article-title: Host MicroRNA hsa‐miR‐494‐3p Promotes EV71 Replication by Directly Targeting PTEN publication-title: Front Cell Infect Microbiol – volume: 382 start-page: 866 year: 2020 article-title: Medical Journals and the 2019‐nCoV Outbreak publication-title: N Engl J Med – volume: 382 start-page: 970 year: 2020 end-page: 971 article-title: Transmission of 2019‐nCoV Infection from an Asymptomatic Contact in Germany publication-title: N Engl J Med – volume: 382 start-page: 929 issue: 10 year: 2020 end-page: 936 article-title: First Case of 2019 Novel Coronavirus in the United States publication-title: N Engl J Med – volume: 26 start-page: 310 issue: 3 year: 2020 end-page: 311 article-title: China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response publication-title: Nat Med – volume: 112 start-page: 3588 issue: 5 year: 2020 end-page: 3596 article-title: Genotyping coronavirus SARS‐CoV‐2: methods and implications publication-title: Genomics – volume: 11 start-page: 2091 year: 2020 end-page: 2100 article-title: Epstein barr virus encodes miRNAs to assist host immune escape publication-title: J Cancer – volume: 9 start-page: 221 year: 2020 end-page: 236 article-title: Genomic characterization of the 2019 novel human‐pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan publication-title: Emerg Microbes Infect – volume: 21 start-page: 5534 year: 2017 end-page: 5541 article-title: The function of miR‐218 and miR‐618 in postmenopausal osteoporosis publication-title: Eur Rev Med Pharmacol Sci – volume: 382 start-page: 872 issue: 9 year: 2020 end-page: 874 article-title: Importation and Human‐to‐Human Transmission of a Novel Coronavirus in Vietnam publication-title: N Engl J Med – volume: 69 start-page: 1891 year: 2017 end-page: 1902 article-title: Association of MicroRNA‐618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis publication-title: Arthritis Rheumatol – volume: 10 start-page: 385 year: 2019 article-title: Micro‐RNAs 518d–3p and 618 Are Upregulated in Individuals With Type 1 Diabetes With Multiple Microvascular Complications publication-title: Front Endocrinol (Lausanne) – volume: 177 start-page: 70 year: 2019 end-page: 78 article-title: Aberrant expression of microRNA in CD4(+) cells contributes to Th17/Treg imbalance in primary immune thrombocytopenia publication-title: Thromb Res – volume: 12 start-page: 23 year: 2020 article-title: Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker publication-title: Gut Pathog – volume: 395 start-page: 473 year: 2020 end-page: 475 article-title: Clinical evidence does not support corticosteroid treatment for 2019‐nCoV lung injury publication-title: Lancet – volume: 12 start-page: 9795 year: 2019 ident: e_1_2_7_21_1 article-title: MicroRNA‐618 Directly Targets Metadherin mRNA To Suppress The Malignant Phenotype Of Osteosarcoma Cells By Reducing PTEN‐AKT Pathway Output publication-title: Onco Targets Ther doi: 10.2147/OTT.S219440 – ident: e_1_2_7_15_1 doi: 10.1186/s13099-020-00353-w – ident: e_1_2_7_2_1 doi: 10.1016/S0140-6736(20)30186-0 – ident: e_1_2_7_11_1 doi: 10.1371/journal.pgen.1008765 – volume: 21 start-page: 5534 year: 2017 ident: e_1_2_7_19_1 article-title: The function of miR‐218 and miR‐618 in postmenopausal osteoporosis publication-title: Eur Rev Med Pharmacol Sci – ident: e_1_2_7_18_1 doi: 10.1016/S0140-6736(20)30317-2 – ident: e_1_2_7_13_1 doi: 10.1002/art.40163 – volume: 11 start-page: 2091 year: 2020 ident: e_1_2_7_14_1 article-title: Epstein barr virus encodes miRNAs to assist host immune escape publication-title: J Cancer doi: 10.7150/jca.42498 – volume: 10 start-page: 385 year: 2019 ident: e_1_2_7_20_1 article-title: Micro‐RNAs 518d–3p and 618 Are Upregulated in Individuals With Type 1 Diabetes With Multiple Microvascular Complications publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2019.00385 – ident: e_1_2_7_3_1 doi: 10.1056/NEJMe2001329 – ident: e_1_2_7_5_1 doi: 10.1126/science.abb8925 – volume: 26 start-page: 310 issue: 3 year: 2020 ident: e_1_2_7_4_1 article-title: China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response publication-title: Nat Med doi: 10.1038/s41591-020-0771-1 – ident: e_1_2_7_12_1 doi: 10.1016/j.thromres.2019.03.005 – ident: e_1_2_7_16_1 doi: 10.3389/fcimb.2018.00278 – ident: e_1_2_7_9_1 doi: 10.1080/22221751.2020.1719902 – ident: e_1_2_7_10_1 doi: 10.1016/j.ygeno.2020.04.016 – ident: e_1_2_7_6_1 doi: 10.1056/NEJMc2001468 – ident: e_1_2_7_7_1 doi: 10.1056/NEJMoa2001191 – ident: e_1_2_7_8_1 doi: 10.1056/NEJMc2001272 – volume: 91 start-page: 195 year: 2020 ident: e_1_2_7_17_1 article-title: The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses publication-title: Acta Biomed |
| SSID | ssj0008916 |
| Score | 2.5744534 |
| Snippet | Introduction
The coronavirus disease (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which play important roles in... The coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which play important roles in regulating gene... IntroductionThe coronavirus disease (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which play important roles in... Extract periperal blood cells from COVID‐19 patients, and micRNAs were detected by high‐throughput sequencing using illumina HiseqX Ten machine to fint the... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e23590 |
| SubjectTerms | Adult Betacoronavirus Bioinformatics Bioinformatics analysis Chromosome 5 Computational Biology Coronaviridae Coronavirus Infections - blood Coronavirus Infections - epidemiology Coronaviruses Correlation analysis COVID-19 Disease Female Gene expression Gene Expression Profiling Health care High-Throughput Nucleotide Sequencing high‐throughput sequencing Humans Immune response Infections Male microRNA MicroRNAs MicroRNAs - blood MicroRNAs - genetics MicroRNAs - metabolism Middle Aged miRNA Pandemics Peripheral blood Pneumonia, Viral - blood Pneumonia, Viral - epidemiology Principal components analysis Protein kinase SARS-CoV-2 Sequence Analysis, RNA Severe acute respiratory syndrome coronavirus 2 Ubiquitin Viral infections Viruses Young Adult |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS-QwEA93Hsi9HOf5tZ5KRF8Uqm3SpumTLKui4geIyj4IJV9FZa-rt7twj_4J_o33l9xMNlsVD98KM9A2k5n8Jpn8hpANLZWN80JExgoZpZpVka6yJHIiscoIABwSLwqfnonDq_S4m3XDhtsglFVOYqIP1LZvcI98h6VZJlIRF2z34THCrlF4uhpaaHwmX5C6DJOvvNskXLEsfOtT70gQiXlDT8p27k1PbTOeYSx-vSC9Q5nviyVfg1i_Ch18J98CfKTtsb1nyCdX_yDTp-GAfJbc7IWGJ-C4PfoLq-0uztrU_Qn1rjW9qylgPooEx55RoEd97TrFeybUd-yjgWt1QHGTlnbOr4_2_j49J8UcuTrYv-wcRqGBQmTSXEBaWGlYfOIq1pngxicvDPFKwrXEO60ydlI4paROuTO2koqD4WxeccWLzGo-T6bqfu0WCbUmkZVNAV4Yg4w0kNeajKkELJ2AKGmRzckoliawi2OTi1455kVmJY546Ue8RdYb3Ycxp8Z_tZYnxiiDXw3Kl1nQImuNGDwCjzlU7foj1IGUMwekxVtkYWy75jWcIRlNDpL8jVUbBWTbfiup72496zbkdaLI4b1b3v4ffHl53Dlp-6elj__hJ_nKMH33tYHLZGr4e-RWAOMM9aqfyP8Assf7IA priority: 102 providerName: ProQuest |
| Title | Differential microRNA expression in the peripheral blood from human patients with COVID‐19 |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcla.23590 https://www.ncbi.nlm.nih.gov/pubmed/32960473 https://www.proquest.com/docview/2455646092 https://www.proquest.com/docview/2444876433 https://pubmed.ncbi.nlm.nih.gov/PMC7536972 |
| Volume | 34 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1faxQxEB9KC-KLtP69Wo-Iviis3SS7SRZ8Oa8ttdizHFbuQViSbBYr51a8FvroR_Az-kmcye5tPSqCL2Ehs-ySySS_SWZ-A_DcGVululCJr5RJMifqxNU5T4LilfUKAYehROHjiTo8zY5m-WwNXi9zYVp-iP7AjSwjrtdk4NYtdq9JQ7_4uX0lZF6gw75BubU0y0V20q_DpoiFT6MZ4Tose3JSsXv97up2dANj3gyV_BPCxj3oYBPudOCRjVptb8FaaO7CrePuevwefNrryp2g2c7ZV4q1m05GLFx10a4NO2sYIj5G9MaRT2DOYuQ6oywTFuv1sY5pdcHoiJaN3398u_frx09e3IfTg_0P48OkK5-Q-EwrdAprh1tPWqcuV9JH10UQWuHSGcpoNWkwKlhrXCaDr2pjJaqt0rW0ssgrJx_AenPehEfAKs9NXWUILrwnPhr0an0uLEc9c-ziA3ixHMXSd9ziVOJiXrasyKKkES_jiA_gWS_7rWXU-KvUzlIZZWdVi1Jkea4ylRZiAE_7brQHuuSwTTi_JBl0ODXiLDmAh63u-s9IQVQ0Gnv0ilZ7AeLaXu1pzj5Hzm306lSh8bsvo_7_8efl0fjdKD5t_4_wY7gtyJWPcYI7sH7x_TI8Qbxz4YZxWmOrZxpbM-ZD2HizPzmZDuMJArVT8RvPWQFX |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VIgEXxD8LBYyAA0ihiZ04zgGh1S7Vbru7SKhFPSAF23FE0ZItbCvgxiPwJDwUT8KM89NWRb31FslWnMyMx9_Y428AnhqlizDNZGALqYLY8DIwZRIFTkaFthIBh6KLwtOZHO3Em7vJ7gr8ae_CUFpl6xO9oy4WlvbI13mcJDKWYcZf738NqGoUna62JTRqs9hyP79jyLZ8NR6ifp9xvvFmezAKmqoCgY1TibFSadAjh2VoEimsR_ScFvFIGEUXPVXolHRaKxMLZ4tSaYF_U6Sl0CJLCiPwvRfgYixESlz9anCUUqIyX2rVT1z0_KKjQ-Xrn-1cv-QiId9_fAE8hWpPJ2ceB81-1du4BlcbuMr6tX1dhxVX3YBL0-ZA_iZ8GDYFVtBRzNkXyu57N-sz96PJr63YXsUQYzIiVPYMBnPmc-UZ3WthvkIga7hdl4w2hdng7fvx8O-v31F2C3bORbS3YbVaVO4usMJGqixihDPWEgMOxtE24TpCy4qwKerB81aKuW3YzKmoxjyveZh5ThLPvcR78KTru19zePy311qrjLyZx8v8yOp68LhrxhlIxyq6cotD6oMhborITvTgTq27bhjBifwmxZb0hFa7DsTufbKl2vvkWb4xjpRZiuO-8Po_48vzzcGk75_unf0Pj-DyaHs6ySfj2dZ9uMJp68DnJa7B6sG3Q_cA8dWBeeiNmsHH855F_wDHvjZ- |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VIlVcEP8sFDACDiCFTezEcQ4IrXZZdfuzIETRHioF23FE0ZItbCvgxiPwPDwOT8KM80Orot56i2QrTjwznm_s8TcAj43SRZhmMrCFVEFseBmYMokCJ6NCW4mAQ9FF4Z2p3NiNN2fJbAV-t3dhKK2yXRP9Ql0sLO2R93mcJDKWYcb7ZZMW8WY0fnnwJaAKUnTS2pbTqFVky_34huHb8sVkhLJ-wvn41bvhRtBUGAhsnEqMm0qDq3NYhiaRwnp0z8mhR8IouvSpQqek01qZWDhblEoL_LMiLYUWWVIYge-9ABdTgW4TbSmddcFeqDJfdtUbMXoB0VGj8v4nO9fPuUjIDxx3hqcQ7ulEzeMA2nvA8RW43EBXNqh17SqsuOoarO00h_PXYW_UFFvBRWPOPlOm39vpgLnvTa5txfYrhniTEbmyZzOYM583z-iOC_PVAlnD87pktEHMhq_fT0Z_fv6Kshuwey5TexNWq0XlbgMrbKTKIkZoYy2x4WBMbROuI9SyCJuiHjxtZzG3DbM5FdiY5zUnM89pxnM_4z141PU9qPk8_ttrvRVG3tj0Mv-ngT142DWjNdIRi67c4oj6YLibIsoTPbhVy64bRnAiwkmxJT0h1a4DMX2fbKn2P3rGb4wpZZbiuM-8_M_48nxzuD3wT3fO_ocHsIb2k29Pplt34RKnXQSforgOq4dfj9w9hFqH5r7XaQYfztuI_gJ--zrg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+microRNA+expression+in+the+peripheral+blood+from+human+patients+with+COVID-19&rft.jtitle=Journal+of+clinical+laboratory+analysis&rft.au=Li%2C+Caixia&rft.au=Hu%2C+Xiao&rft.au=Li%2C+Leilei&rft.au=Li%2C+Jin-Hui&rft.date=2020-10-01&rft.issn=1098-2825&rft.eissn=1098-2825&rft.volume=34&rft.issue=10&rft.spage=e23590&rft_id=info:doi/10.1002%2Fjcla.23590&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0887-8013&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0887-8013&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0887-8013&client=summon |